AR012638A1 - Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional - Google Patents
Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacionalInfo
- Publication number
- AR012638A1 AR012638A1 ARP980102025A ARP980102025A AR012638A1 AR 012638 A1 AR012638 A1 AR 012638A1 AR P980102025 A ARP980102025 A AR P980102025A AR P980102025 A ARP980102025 A AR P980102025A AR 012638 A1 AR012638 A1 AR 012638A1
- Authority
- AR
- Argentina
- Prior art keywords
- pregnan
- manufacture
- onas
- medicinal product
- therapy
- Prior art date
Links
- 238000002560 therapeutic procedure Methods 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 230000001072 progestational effect Effects 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- AURFZBICLPNKBZ-SRJHXTLLSA-N 3-hydroxypregnan-20-one Chemical class C1CC2CC(O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 AURFZBICLPNKBZ-SRJHXTLLSA-N 0.000 abstract 1
- JWMFYGXQPXQEEM-UHFFFAOYSA-N 5alpha-Pregnan Natural products C1CC2CCCCC2(C)C2C1C1CCC(CC)C1(C)CC2 JWMFYGXQPXQEEM-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional a un mamífero que necesita de dicha terapiaque comprende administrar una cantidad progestacionalmente efectiva de una sal farmacéuticamente aceptable de 3-sulfatoéster de 5alfa-pregnan-3beta-ol-20-onaa dicho mamífero.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85056797A | 1997-05-02 | 1997-05-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012638A1 true AR012638A1 (es) | 2000-11-08 |
Family
ID=25308504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102025A AR012638A1 (es) | 1997-05-02 | 1998-04-30 | Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0981349B1 (es) |
| JP (1) | JP2001525807A (es) |
| KR (1) | KR20010012157A (es) |
| CN (1) | CN1254283A (es) |
| AR (1) | AR012638A1 (es) |
| AT (1) | ATE227130T1 (es) |
| AU (1) | AU739146B2 (es) |
| BR (1) | BR9809376A (es) |
| CA (1) | CA2289006A1 (es) |
| DE (1) | DE69809223T2 (es) |
| DK (1) | DK0981349T3 (es) |
| ES (1) | ES2186153T3 (es) |
| PT (1) | PT981349E (es) |
| WO (1) | WO1998050042A1 (es) |
| ZA (1) | ZA983705B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3877961B2 (ja) * | 1998-03-11 | 2007-02-07 | ベクストルム，トルビエーン | Ｃｎｓ疾患の治療におけるエピアロプレグナノロン |
| SE0104423D0 (sv) * | 2001-12-27 | 2001-12-27 | Umecrine Ab | Pregnane steroids and their use in the treatment of CNS disorders |
| US7572780B2 (en) | 2003-01-21 | 2009-08-11 | Dimera, Incorporated | Method and kit for reducing the symptoms of peripheral vascular disease |
| US7473687B2 (en) | 2005-03-24 | 2009-01-06 | Emory University | Methods for the treatment of a traumatic central nervous system injury |
| DK1868614T3 (da) | 2005-03-24 | 2012-11-12 | Univ Emory | Dosisregime til behandling af en traumatisk hjerneskade med progesteron |
| WO2006117592A1 (en) * | 2005-04-29 | 2006-11-09 | Inserm | Methods of modulating nuclear receptors |
| JP5687287B2 (ja) | 2010-01-14 | 2015-03-18 | ウメクライン ムード エービー | 改善された保存性及び溶解特性を有する３−ベータ−ヒドロキシ−５−アルファ−プレグナン−２０−オンを含有する薬学的組成物 |
-
1998
- 1998-04-28 CA CA002289006A patent/CA2289006A1/en not_active Abandoned
- 1998-04-28 WO PCT/US1998/008456 patent/WO1998050042A1/en not_active Ceased
- 1998-04-28 ES ES98918789T patent/ES2186153T3/es not_active Expired - Lifetime
- 1998-04-28 BR BR9809376-2A patent/BR9809376A/pt not_active IP Right Cessation
- 1998-04-28 AU AU71647/98A patent/AU739146B2/en not_active Ceased
- 1998-04-28 EP EP98918789A patent/EP0981349B1/en not_active Expired - Lifetime
- 1998-04-28 DE DE69809223T patent/DE69809223T2/de not_active Expired - Fee Related
- 1998-04-28 JP JP54815598A patent/JP2001525807A/ja active Pending
- 1998-04-28 PT PT98918789T patent/PT981349E/pt unknown
- 1998-04-28 CN CN98804719A patent/CN1254283A/zh active Pending
- 1998-04-28 KR KR19997010102A patent/KR20010012157A/ko not_active Withdrawn
- 1998-04-28 AT AT98918789T patent/ATE227130T1/de not_active IP Right Cessation
- 1998-04-28 DK DK98918789T patent/DK0981349T3/da active
- 1998-04-30 AR ARP980102025A patent/AR012638A1/es unknown
- 1998-04-30 ZA ZA9803705A patent/ZA983705B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69809223T2 (de) | 2003-07-24 |
| DK0981349T3 (da) | 2003-03-10 |
| AU739146B2 (en) | 2001-10-04 |
| CN1254283A (zh) | 2000-05-24 |
| CA2289006A1 (en) | 1998-11-12 |
| PT981349E (pt) | 2003-01-31 |
| EP0981349B1 (en) | 2002-11-06 |
| KR20010012157A (ko) | 2001-02-15 |
| ZA983705B (en) | 1999-11-01 |
| WO1998050042A1 (en) | 1998-11-12 |
| JP2001525807A (ja) | 2001-12-11 |
| ES2186153T3 (es) | 2003-05-01 |
| EP0981349A1 (en) | 2000-03-01 |
| BR9809376A (pt) | 2000-07-04 |
| DE69809223D1 (de) | 2002-12-12 |
| AU7164798A (en) | 1998-11-27 |
| ATE227130T1 (de) | 2002-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
| ES2156840T1 (es) | Medicamento que contiene polisulfato de pentosano e implante para tratar la fibrosis. | |
| CO5011096A1 (es) | Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs | |
| CL2008003938A1 (es) | Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00). | |
| CY1105707T1 (el) | Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου | |
| ES2062392T3 (es) | Medicamentos que comprenden salmeterol y fluticasona. | |
| ATE286725T1 (de) | Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe | |
| BR9604880A (pt) | Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica | |
| YU37301A (sh) | Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa | |
| AR002355A1 (es) | Composiciones y metodos para administracion local de agentes farmaceuticamente activos. | |
| ATE216220T1 (de) | Osmotische darreichungsform mit zwei mantelschichten | |
| BR9708706B1 (pt) | composiÇço farmacÊutica para administraÇço intravenosa a um paciente | |
| UY26372A1 (es) | "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen " | |
| AR011114A1 (es) | COMPOSICIoN FARMACÉUTICA LIBRE DE LACTOSA EN FORMA GRANULADA O EN MEZCLA PARA EL TRATAMIENTO DE DESoRDENES INDUCIDOS POR HISTAMINA. | |
| PT957899E (pt) | Forma de dosagem para proporcionar um medicamento numa dose crescente | |
| AR004700A1 (es) | 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento | |
| BR9916860A (pt) | Método de reduzir colesterol do sangue e/outriglicerìdios do sangue em um indivìduo mamìfero,preparação em forma de unidade de dosagem, e,conjunto para administrar oralmente a mesma | |
| FR2735369B1 (fr) | Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside | |
| EA199800717A1 (ru) | Способ лечения заболеваний млекопитающих и цвиттерионная композиция | |
| AR023699A1 (es) | Una composicion farmaceutica que comprende un estabilizador de insulina y un procedimiento para preparar una composicion farmaceutica | |
| AR012638A1 (es) | Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional | |
| ES2148493T3 (es) | Nuevos compuestos con efecto analgesico y anestesico local. | |
| FR2767526B1 (fr) | Composes bi-aromatiques relies par un radical heteroethynylene et compositions pharmaceutiques et cosmetiques les contenant | |
| AR012996A1 (es) | Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador. | |
| TR199901237T2 (xx) | Bir tienilsiklohegzilamin t�revinin tedavide yeni uygulamas�. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |